Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022

Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release

Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study

Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result

Anavex Life Sciences Announces ANAVEX®2-73 Improved both Primary Cognitive and Second MDS-UPDRS

Anavex Life Sciences Reports the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B)

Anavex Life Sciences Presents Proof of Concept Controlled Phase 2 Clinical Trial Data

Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Trial

Anavex Life Sciences Announces Commitment for Financial Investment by Shake It Up Foundation